Pfizer's Talzenna therapy accepted for use within NHS Scotland - PharmaTimes Scottish Medicines Consortium approves new option for mCRPC patients

#prostatecancer #Pfizer #Talzenna #talazoparib #Talzennatherapy #NHSScotland #ScottishMedicinesConsortium #SMCapprovel #mCRPCpatients #metastaticcastrationresistantprostatecancer #mCRPC #polyADPribosepolymeraseinhibitor #PARPinhibitor #metastaticprostatecancer
pharmatimes.com/news/pfizers...